ENDO: Primary Aldosteronism Screening Recommended for All With Hypertension
Screening should include measuring aldosterone and renin and determining the aldosterone-to-renin ratio
ENDO: Osteoporosis Treatment Benefits Elderly Patients With Fragility Fracture
Benefits include lower incidence of all-cause mortality, hospitalizations
GLP-1 Receptor Agonist Use in T2D Tied to Increased Risk for GERD, GERD Complications
Risk ratios were 1.27 and 1.55 for GERD and its complications during a median follow-up of three years for GLP-1 RA versus SGLT-2 inhibitor users
Long-Term Obesity Linked to Expression of Aging Biomarkers
Association seen for long-term obesity with adulthood expression of biomarkers denoting antagonistic and integrative aging hallmarks
ENDO: Older Age, Female Sex Tied to Greater Muscle Loss With Semaglutide
Higher protein intake may be protective against muscle loss, which is tied to less improvement in glucose homeostasis
U.S. Children Became Increasingly Unhealthy in Recent Decades
Deterioration seen for mortality and across a range of chronic physical, developmental, and mental health conditions
Most U.S. Adults Lack Awareness of Processed Foods
Authors propose replacing the term 'processed foods' with more specific terms describing foods’ known health effects
ENDO: 1999 to 2020 Saw Significant Uptick in Obesity-Related Cancer Deaths
Highest mortality rates seen among older adults, rural populations, and those in the Midwest
Certain Factors May Predict Weight Fluctuations After GLP-1 Receptor Agonist Treatment
Longer treatment duration, using semaglutide, higher percentage body fat, and nondiabetic status may be associated with better weight reduction
ENDO: Superior Weight Loss Seen With Tirzepatide and Menopausal Hormone Therapy Use
For postmenopausal women with overweight or obesity receiving tirzepatide, menopausal hormone therapy linked to increased weight loss
